Study title: Erythrocyte Sodium-Lithium Countertransport and Proliferative Diabetic Retinopathy.Invest Ophthalmol Vis Sci. 2000 May;41(6):1482-5.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: | |||||
Brands: | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: SODIUM CHROMATE | |||||
ATC code: | |||||
Document link: 2011-09 GE response Sodium Chromate List of published articles.doc | |||||
Document date: 2013-11-08 | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Review Article | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |